Cipla, India's third-largest generic drugmaker by sales, reported a 15.2% rise in second-quarter profit that beat estimates, driven by higher sales of its respiratory and cancer drugs in its key North America and India markets.

Engineers India Q2 Results Live : Engineers India declared their Q2 results on 29 October 2024, revealing a significant decline in financial performance. The company's topline revenue decreased by 12.77% year-over-year, while profit fell by 21.83% during the same period.

Drug major Cipla on Tuesday reported a 17 per cent increase in consolidated net profit to Rs 1,303 crore for the second quarter ended September 2024, driven by robust sales across markets

India's Adani Enterprises reported a more than seven-fold surge in second-quarter profit on Tuesday, as higher demand in its renewable energy division overshadowed weakness in the mainstay coal trading segment.

The Mumbai-based firm’s consolidated revenue from operations rose to ₹7,051.02 crore in the September quarter, up from ₹6,678.15 crore a year ago.

Cipla posted a 15.2% rise/decline in its net profit for the second quarter of the financial year, though shares were still in the red on Tuesday. What Happened: India’s third-largest pharmaceutical company said its net profit attributable to owners came in at ₹1,

Indian consumer goods maker Marico reported second-quarter profit well above market estimates on Tuesday, propped up by price hikes undertaken to offset higher raw material prices.

Pharma major Cipla Ltd on Tuesday reported an 15.2% year-on-year rise in its consolidated net profit for the fiscal's second quarter ended September (Q2FY25) to ₹1,303.53 crore. The company had reported a profit of ₹1,